scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.TRANSPROCEED.2008.03.102 |
P8608 | Fatcat ID | release_fmxf4j3lfzg7xpdln35jwuc3si |
P698 | PubMed publication ID | 18589191 |
P2093 | author name string | W C Liles | |
A V Page | |||
P2860 | cites work | Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey | Q24816756 |
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 | ||
Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis | Q35352934 | ||
American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006. | Q36881638 | ||
Chronic therapy with recombinant tumor necrosis factor-alpha in autoimmune NZB/NZW F1 mice. | Q45993090 | ||
Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective? | Q47362771 | ||
Accumulation of plasma nucleosomes upon treatment with anti-tumour necrosis factor-alpha antibodies. | Q51052396 | ||
Drug-induced lupus: an update | Q56224756 | ||
Autoimmune Diseases Induced by TNF-Targeted Therapies | Q56907567 | ||
In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL | Q77337880 | ||
Infliximab for ulcerative colitis following liver transplantation | Q79777123 | ||
Primary sclerosing cholangitis | Q81326220 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | fever of unknown origin | Q1405631 |
P304 | page(s) | 1768-1770 | |
P577 | publication date | 2008-06-01 | |
P1433 | published in | Transplantation Proceedings | Q7834825 |
P1476 | title | Tumor necrosis factor-alpha inhibitor-induced lupus-like syndrome presenting as fever of unknown origin in a liver transplant recipient: case report and concise review of the literature | |
P478 | volume | 40 |
Q37354812 | Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomes |
Q82540859 | Infliximab as therapeutic option in steroid-refractory ulcerative colitis after kidney transplantation: case report |
Q37406698 | Lupus-like syndrome attributable to anti-tumor necrosis factor alpha therapy in 14 patients during an 8-year period at Mayo Clinic |
Q35808834 | Onset of lupus like syndrome in patients with spondyloarthritis treated with anti-TNF-α. |
Search more.